Multi-parametric MRI is the gold standard for neuro-oncology, yet acquiring complete 4-modality protocols may be unfeasible in real-world clinical practice. When handling missing modalities, existing...
CAPS is a Clinically‑Verifiable Anatomy‑Prioritized Synthesis framework designed to impute missing MRI modalities for brain tumor segmentation. It uses a hybrid loss (L₁ + L_AFP + L_DualDice) to preserve deep anatomical features and topological boundaries, achieving high synthesis fidelity and robust segmentation (82.38% mean Dice) on the BraTS Adult Glioma dataset. The method also generalizes well to unseen cohorts and has been validated by blinded radiologists, who report improved image quality and clinical utility.
By Cecilia Diana-Albelda, Arthur Longuefosse, Mario Rub\'en Paz Campos, \'Alvaro Garc\'ia-Mart\'in, Jesus Bescos
arXiv:2606. 19300v1 Announce Type: cross Abstract: Glioma segmentation in multiparametric MRI is a critical component of treatment planning.
By Xin Ci Wong, Duygu Sarikaya, Kieran Zucker, Marc De Kamps, Nishant Ravikumar
arXiv:2607. 22727v1 Announce Type: cross Abstract: Medical image segmentation models often report high benchmark accuracy under ideal imaging conditions, yet their failures under clinical degradation can be quiet: sensor noise, patient motion, low- resolution acquisition, and contrast variability may all alter model behavior without producing an obvious warning.
By Pranav Kaliaperumal, Manisha Kaliaperumal
arXiv:2606. 30374v1 Announce Type: cross Abstract: Multimodal MRI is essential for accurate brain tumor segmentation.
By Seunghun Baek, Jihwan Park, Jaeyoon Sim, Hoseok Lee, Seungjoo Lee, Won Hwa Kim
The paper introduces MSM‑Seg, a dual‑memory segmentation framework for 3D multi‑modal brain tumor segmentation. It combines a modality‑and‑slice memory attention module to capture cross‑modal and spatial‑slice dependencies, a multi‑scale category‑agnostic prompt encoder for whole‑tumor guidance, and a modality‑adaptive fusion decoder to integrate complementary decoding information. Experiments on various MRI datasets show that MSM‑Seg surpasses state‑of‑the‑art methods for metastases and glioma tumor segmentation.
By Yuxiang Luo, Qing Xu, Hai Huang, Yuqi Ouyang, Xiangjian He, Zhen Chen, Wenting Duan, Jiebo Luo